Americans preparing to enroll in 2026 Affordable Care Act (ACA) health insurance plans are facing steep premium hikes, with monthly costs expected to more than double on average. The sharp rise stems from the expiration of COVID-19 pandemic-era subsidies that have been central to the ongoing U.S. government shutdown. These subsidies, which boosted enrollment to a record 24 million since 2021, are set to expire at the end of the year, potentially increasing the number of uninsured Americans and influencing election outcomes.
According to health research firm KFF, ACA enrollees will see average premiums rise by 114%. While 22 million people currently receive subsidies, the impact will vary widely. For example, 24-year-old Californian Austin Jeha’s monthly premium is expected to jump from $215 to $436. Like many, he relies on his ACA plan for essential medical care and is urging Congress to extend the subsidies.
The budget impasse in Washington has left much of the government shuttered since October 1. Democrats are pushing to include ACA funding in any reopening deal, while Republicans insist on restoring government funding first. Residents of Republican-led states such as Florida, Texas, and Georgia are expected to be hit hardest, as limited Medicaid coverage forces many low-income workers to depend on ACA plans.
If subsidies expire, households earning just above 400% of the federal poverty line—around $84,600 for a couple—could see their premiums quadruple. Experts warn enrollment will decline even if subsidies are later reinstated, as consumers may abandon plans after seeing higher rates. The Congressional Budget Office estimates over 4 million Americans could lose coverage without renewed tax credits. Rising healthcare costs and insurer exits, such as CVS Health’s Aetna leaving the ACA market, have already driven a 26% increase in premiums. For many families, healthcare remains essential but increasingly unaffordable.


Trump Extends AGOA Trade Program for Africa Through 2026, Supporting Jobs and U.S.-Africa Trade
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Minnesota Judge Rejects Bid to Halt Trump Immigration Enforcement in Minneapolis
FDA Fast-Track Drug Reviews Delayed Over Safety and Efficacy Concerns
Marco Rubio Steps Down as Acting U.S. Archivist Amid Federal Law Limits
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Pentagon and Anthropic Clash Over AI Safeguards in National Security Use
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Trump Appoints Colin McDonald as Assistant Attorney General for National Fraud Enforcement
Thailand Inflation Remains Negative for 10th Straight Month in January 



